Trials / Withdrawn
WithdrawnNCT01522040
Pilot Study of Magnesium Infusions in Pediatric Asthma
A Pilot Study of Magnesium Infusions (Drips) for Moderate-to-Severe Pediatric Asthma Exacerbations
- Status
- Withdrawn
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Louisville · Academic / Other
- Sex
- All
- Age
- 2 Years – 20 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective randomized pilot study that seeks to address the research question: In children with moderate-to-severe asthma, do intravenous magnesium infusions added to standard Pediatric intensive care unit (PICU)-level asthma care significantly decrease time from patient presentation until PICU discharge?
Detailed description
This study will be a double-blind, prospective randomized pilot study. Subjects will be randomized on a 1:1 basis to receive routine asthma care with or without a magnesium drip.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Magnesium Sulfate | Continuous magnesium drip, titrated to effect until patient's symptoms improve |
| DRUG | Placebo | Simple saline drip, without active drug |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
- First posted
- 2012-01-31
- Last updated
- 2017-03-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01522040. Inclusion in this directory is not an endorsement.